Font Size: a A A
Keyword [Metastatic breast cancer]
Result: 121 - 140 | Page: 7 of 7
121. Expression And Clinicopathological Significance Of BRD4 And Epithelial-mesenchymal Transition Related Protein In Metastatic Breast Cancer
122. Single Positive Hormone Receptor:Clinicopathologic And Prognosis In Stage Ⅳ Breast Cancer With Negative HER-2
123. Predictive Analysis Of Multiple Tumor Markers In The Diagnosis Of Metastatic Breast Cancer
124. The Effect Of Tablysin-15 Against Metastatic Breast Cancer And Bone Destruction Diseases Via Blocking Integrin αvβ3
125. Clinical Implications Of TP53 Mutations In Metastatic Breast Cancer
126. Retrospective Analysis Of Clinical Features And Prognosis Between Metaplastic Breast Cancer And Triple Negative Breast Cancer
127. A Study Of The Correlation Between Gemcitabine Efficacy And Clinical,Pathological Characteristics And PROM2 Expression In Treating Metastatic Breast Cancer Patients
128. Establishment And Validation Of Survival Prediction Model In Patients With Ⅳ Breast Cancer
129. Analysis Of De Novo And Recurrent Metastatic Breast Cancer With HER2-negative
130. The Study On Tumor Microenvironment-responsive Gene/Drug Nanosystem For Chemo-immune Combination Therapy On Metastatic Breast Cancer
131. Screening And Identification Of The Binding Target Molecular Of BRBP1 Which Targets To Human Brain Metastatic Breast Cancer Cells
132. Analysis Of Clinicopathologic Characteristics And Prognosis Of De Novo Metastatic Breast Cancer
133. The Analysis Of Survival And The Fragmentation Patterns Of Urinary Cell-free DNA Of Metastatic Breast Cancer Patients
134. Individualized Diagnosis And Treatment Strategy For Metastatic Breast Cancer Based On Circulating Tumor DNA
135. Expression And Clinical Significance Of Serum MicroRNA-195 In Recurrent And Metastatic Breast Cancer
136. Efficacy And Safety Of Pyrotinib-Based Regimens In HER2 Positive Metastatic Breast Cancer:A Retrospective Real-World Data Study
137. Effect Of Primary Tumor Resection And Establishment Of A Nomogram Predicts The Breast Cancer-specific Survival In Patients With De Novo Metastatic Breast Cancer
138. Real-world Benefit Of Combination Abemaciclib And Endocrine Therapy For Metastatic Breast Cancer And Correlation With Neutropenia
139. Analysis Of The Clinical Characteristics And Prognosis Of Patients With Bone Metastatic Breast Cancer With Different Hormone Receptor Status
140. Pyrotinib Treatment In Patients With HER2-Positive Metastatic Breast Cancer:A Real-World,Multicenter Analysis
  <<First  <Prev  Next>  Last>>  Jump to